Suppr超能文献

荷兰抑郁与焦虑研究中的重度抑郁症、抗抑郁药使用及随后两年的体重变化模式

Major depressive disorder, antidepressant use, and subsequent 2-year weight change patterns in the Netherlands Study of Depression and Anxiety.

作者信息

Gibson-Smith Deborah, Bot Mariska, Milaneschi Yuri, Twisk Jos W, Visser Marjolein, Brouwer Ingeborg A, Penninx Brenda W J H

机构信息

GGZ inGeest, A.J. Ernststraat 1187, 1081 HL, Amsterdam, The Netherlands

出版信息

J Clin Psychiatry. 2016 Feb;77(2):e144-51. doi: 10.4088/JCP.14m09658.

Abstract

BACKGROUND

Although depression and obesity are bidirectionally associated, little is known about weight changes following major depressive disorder (MDD). This study compared 2-year weight changes between patients with current MDD (cMDD), patients with remitted MDD (rMDD), and healthy controls. Additionally, we examined the relationship between antidepressant medication use and 2-year weight change.

METHOD

Data from 2,542 adults aged 18-65 y were sourced from the Netherlands Study of Depression and Anxiety. Data were collected at baseline and after 2, 4, and 6 years (September 2004-April 2013). Depression status (DSM-IV criteria for MDD) was established with the Composite International Diagnostic Interview. Subsequent 2-year weight changes were categorized as weight loss (> 5% loss), weight stable (within 5% weight loss or gain), and weight gain (> 5% gain). The association of depression status with subsequent weight change, with weight stable as reference category, was studied by combining all repeated measurements in a mixed multinomial logistical regression model.

RESULTS

cMDD, but not rMDD, was significantly associated with both weight gain and weight loss over a 2-year period after adjustment for covariates (odds ratio [OR] = 1.67; 95% confidence interval [CI], 1.37-2.03; P < .001; and OR = 1.27; 95% CI 1.01-1.61; P = .045, respectively). Antidepressant use was associated with weight gain (SSRIs: OR = 1.26; 95% CI, 1.05-1.52; other antidepressants: OR = 1.36; 95% CI, 1.00-1.84; P < .05 for both), but not after considering depression status. Compared to cMDD patients who lost weight, those who gained weight had lower initial weight, were younger, had more comorbid anxiety disorders, and reported poorer quality of mood and reduced appetite as depressive symptoms.

CONCLUSIONS

Compared to controls, cMDD participants have greater odds of either gaining or losing weight over a 2-year period, regardless of antidepressant use.

摘要

背景

尽管抑郁症和肥胖症存在双向关联,但对于重度抑郁症(MDD)后的体重变化知之甚少。本研究比较了当前患有MDD(cMDD)的患者、已缓解的MDD(rMDD)患者和健康对照者之间的2年体重变化。此外,我们还研究了抗抑郁药物使用与2年体重变化之间的关系。

方法

来自荷兰抑郁症和焦虑症研究的2542名18 - 65岁成年人的数据。在基线以及2年、4年和6年后(2004年9月 - 2013年4月)收集数据。使用综合国际诊断访谈确定抑郁症状态(MDD的DSM - IV标准)。随后的2年体重变化分为体重减轻(>5%减轻)、体重稳定(体重减轻或增加在5%以内)和体重增加(>5%增加)。通过在混合多项逻辑回归模型中合并所有重复测量值,研究抑郁症状态与随后体重变化的关联,以体重稳定作为参考类别。

结果

在对协变量进行调整后,cMDD患者而非rMDD患者在2年期间体重增加和体重减轻均有显著关联(优势比[OR]=1.67;95%置信区间[CI],1.37 - 2.03;P<. .001;以及OR = 1.27;95% CI 1.01 - 1.61;P = .045)。使用抗抑郁药物与体重增加相关(选择性5-羟色胺再摄取抑制剂[SSRIs]:OR = 1.26;95% CI,1.05 - 1. (此处原文有误,应为1.52);其他抗抑郁药物:OR = 1.36;95% CI,1.00 - 1.84;两者P<. .05),但在考虑抑郁症状态后则不然。与体重减轻的cMDD患者相比,体重增加的患者初始体重较低、更年轻、合并焦虑症更多,并且报告情绪质量较差以及食欲下降作为抑郁症状。

结论

与对照组相比,cMDD参与者在2年期间无论是否使用抗抑郁药物,体重增加或减轻几率均更高。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验